港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

長風藥業

32.320

+1.8205.97%

成交量：42.44萬

成交額：1,354.85萬

市值：133.15億

市盈率：519.60

高：32.500

開：31.000

低：30.880

收：30.500

52周最高：48.800

52周最低：27.200

股本：4.12億

香港流通股本：3.02億

量比：1.84

換手率：0.14%

股息：- -

股息率：- -

每股收益(LYR):0.062

淨資產收益率：-5.62%

總資產收益率：-5.30%

市淨率：12.70

市盈率(LYR):519.60

市銷率: 20.16

資料載入中...

總覽公司新聞資訊公告

長風藥業(02652.HK)：建議採納H股獎勵計劃

博遠10月月報長風藥業成功登陸港交所主板，賽陸完成數千萬元B1輪孖展

長風藥業11月11日主力淨流入46.5萬元散户資金拋售

長風速遞丨長風藥業榮膺中國證券報「成長價值金牛獎」，深耕吸入製劑十數載再獲權威認可

【IPO月報】10月IPO賺錢效應繼續：金葉超購逾萬倍長風藥業首日可賺萬七

智通財經港股11月投資策略及十大金股

長風速遞 | 長風藥業(2652. HK)與九州通全擎健康簽署戰略合作協議

從本土突圍到全球破局，長風藥業港交所上市，劍指吸入製劑高地

200億，中國藥谷又跑出一個IPO

周律微金融

長風速遞丨長風藥業治療肺氣腫領域的微創介入器械完成首例入組

中国医药创新促...

港股異動 | 長風藥業(02652)午前漲近3% 公司治療肺氣腫領域的微創介入器械完成首例入組

是時候在一個新的維度看長風藥業的「藥械組合」了，一口呼吸如何撬動千億級藍海？

中國創新藥市場爆發，港股迎來呼吸製劑明星

長風藥業10月16日主力淨流出43.7萬元散户資金買入

長風速遞丨長風藥業吸入創新藥入選蘇州市「關鍵核心技術攻關」項目

長風藥業(2652.HK)登陸港股，稀缺性、成長性與確定性兼具

長風藥業10月15日獲主力加倉55.1萬元

長風藥業10月13日主力淨流出26.8萬元散户資金買入

一週港股牛熊榜 | 周內飆升26%！恒生銀行獲滙豐私有化；中興通訊周升16%，股價本週創新高；山高控股周跌25%，遭恒生公司官宣剔除系列指數

老虎资讯综合

越亞半導體擬募資超12億，18C企業魔視智能、森億智能遞表港交所

Ofweek光电信息网

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02652/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"長風藥業","latestPrice":32.32,"timestamp":1763366893787,"preClose":30.5,"halted":0,"volume":424400,"delay":0,"floatShares":302223586,"shares":411978387,"eps":0.06220219346262971,"marketStatus":"未開盤","change":1.82,"latestTime":"11-17 16:08:13","open":31,"high":32.5,"low":30.88,"amount":13548498,"amplitude":0.053115,"askPrice":32.4,"askSize":4500,"bidPrice":32.32,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0.08185569799059425,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":0,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":30.5,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"volumeRatio":1.83564,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":302223586,"roa":"-5.30%","roe":"-5.62%","lyrEps":0.062202,"volumeRatio":1.83564,"shares":411978387,"dividePrice":0,"high":32.5,"amplitude":0.053115,"preClose":30.5,"low":30.88,"week52Low":27.2,"pbRate":"12.70","psRate":"20.16","week52High":48.8,"institutionHeld":0,"latestPrice":32.32,"committee":-0.636364,"eps":0.06220219346262971,"divideRate":0,"volume":424400,"delay":0,"ttmEps":0.08185569799059425,"open":31,"prevYearClose":14.75,"prevWeekClose":30.5,"prevMonthClose":30.3,"prevQuarterClose":14.75,"fiveDayClose":29,"twentyDayClose":29.46,"sixtyDayClose":14.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2025-11-14","current":394.967687,"percent":0.884615,"low":-293.764894,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"high":450.433063,"avg":375.248585,"sd":132.0415,"marketCap":12565340803},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803}],"updateTime":1763378658945},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583558462","title":"長風藥業(02652.HK)：建議採納H股獎勵計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=2583558462","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583558462?lang=zh_tw&edition=fundamental","pubTime":"2025-11-13 07:27","pubTimestamp":1762990021,"startTime":"0","endTime":"0","summary":"格隆汇11月13日丨长风药业(02652.HK)发布公告，2025年11月12日，其已决议建议采纳公司2025年H股奖励信托计划(“H股奖励计划”)。H股奖励计划旨在使公司雇员、管理层及股东(“股东”)的利益趋于一致，吸引、挽留并激励关键人才，回报其贡献，推动公司持续发展及长远成功。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251113/31789806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02652"],"gpt_icon":0},{"id":"2582946341","title":"博遠10月月報長風藥業成功登陸港交所主板，賽陸完成數千萬元B1輪孖展","url":"https://stock-news.laohu8.com/highlight/detail?id=2582946341","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582946341?lang=zh_tw&edition=fundamental","pubTime":"2025-11-12 09:32","pubTimestamp":1762911120,"startTime":"0","endTime":"0","summary":"10月医疗行业融资动态：长风药业10月8日于香港联交所主板上市，全球发售4119.8万股H股，每股14.75港元，募集资金净额约525.4百万港元，资金用于吸入制剂研发、临床前研发及生产设施升级等；赛陆医疗近日完成数千万元B1轮融资，投资方为艾德生物，财务顾问未提及，融资资金将用于全国产测序平台注册申报、产能扩建及全球化市场拓展。研究进展方面，欧科健FIC眼科双抗新药OCUL101完成PIb期SAD研究，展现出良好安全性与持久疗效趋势；景杰生物科学顾问赵英明受邀赴瑞典参会2025诺贝尔年度论坛并发表演讲。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511120953259763a292&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511120953259763a292&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2582419283","title":"長風藥業11月11日主力淨流入46.5萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2582419283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582419283?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 16:15","pubTimestamp":1762848947,"startTime":"0","endTime":"0","summary":"11月11日, 长风药业股价涨3.66%，报收30.06元，成交金额865.7万元，换手率0.10%，振幅6.76%，量比1.52。长风药业今日主力资金净流入46.5万元，上一交易日主力净流出0万元。该股近5个交易日上涨3.35%，主力资金累计净流出81.1万元；近20日主力资金累计净流出412.1万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111162056a6f17bbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111162056a6f17bbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2582135526","title":"長風速遞丨長風藥業榮膺中國證券報「成長價值金牛獎」，深耕吸入製劑十數載再獲權威認可","url":"https://stock-news.laohu8.com/highlight/detail?id=2582135526","media":"长风药业","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582135526?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 12:29","pubTimestamp":1762835384,"startTime":"0","endTime":"0","summary":"关于金牛奖“金牛奖”是由中国证券报主办的权威奖项评选。长风药业吸入制剂再获海外新市场突破长风速递丨长风药业治疗肺气肿领域的微创介入器械完成首例入组长风速递丨长风药业吸入创新药入选苏州市“关键核心技术攻关”项目","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111142746a6f13b8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111142746a6f13b8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2580163264","title":"【IPO月報】10月IPO賺錢效應繼續：金葉超購逾萬倍 長風藥業首日可賺萬七","url":"https://stock-news.laohu8.com/highlight/detail?id=2580163264","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580163264?lang=zh_tw&edition=fundamental","pubTime":"2025-11-03 16:09","pubTimestamp":1762157343,"startTime":"0","endTime":"0","summary":"10月新股IPO数量继续保持高位，认购情绪高涨，金叶国际集团认购倍数超万倍，同时，多只新股上市首日表现亮眼，市场交投活跃度显著提升，为香港资本市场注入新活力。业绩表现方面，10月30日，公司发布前三季度业绩，归属于上市公司股东的净利润约71.36亿元，同比增长46.58%;基本每股收益0.8455元。不过需要注意的是，长风药业在上市后未能延续首日的强劲走势，股价出现接连数日的回吐行情。目前，已获上市委员会批准，待上市数量为19家。","market":"other","thumbnail":"https://static.szfiu.com/news/20220324/YzUxYTE2NDgwOTA4NjcwODA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/YzUxYTE2NDgwOTA4NjcwODA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1968923","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00638","08549","BK1148","BK1191","BK1214","02637","BK1149","06031","06687","BK1171","BK1240","02575","02650","BK1109","02670","02652"],"gpt_icon":1},{"id":"2580747285","title":"智通財經港股11月投資策略及十大金股","url":"https://stock-news.laohu8.com/highlight/detail?id=2580747285","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580747285?lang=zh_tw&edition=fundamental","pubTime":"2025-11-02 19:20","pubTimestamp":1762082452,"startTime":"0","endTime":"0","summary":"据新华网报道，美国联邦最高法院此前宣布，将快速审议特朗普政府征收的多数关税的合法性，并于11月5日听取口头辩论。美国总统特朗普表示，其可能亲自前往最高法院旁听关税合法性的口头辩论。美参议院有关推进拨款法案停止政府“停摆”的下一次表决最早将于11月3日晚开始。2025年11月投资策略：拥抱抗跌的品种智通财经10月金股小幅跑赢大盘。10月同期恒指最大涨幅2%;十大金股10月平均最大涨幅6.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1183","01157","BK1148","BK1175","IE00BGHQDM52.EUR","LU2097828714.EUR","00670","02652","01618","02600","02533","LU0314109678.HKD","02313","01888","08549","IE00B5MMRT66.SGD","BK1221","BK1588","SG9999001051.SGD","01138","01164","03692","02382","01635","00027","01385","03759","03877","09880","BK1119","BK1521","LU1328615791.USD","CIF","IE00BMCWC346.EUR","00826","03898","BK1169","BK1548","IE0008369823.USD","01277","03800","06682","00631","SG9999003461.SGD","BK1576","09696"],"gpt_icon":1},{"id":"2578465526","title":"長風速遞 | 長風藥業(2652. HK)與九州通全擎健康簽署戰略合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2578465526","media":"长风药业","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578465526?lang=zh_tw&edition=fundamental","pubTime":"2025-10-27 09:29","pubTimestamp":1761528596,"startTime":"0","endTime":"0","summary":"2025年10月23日，长风药业股份有限公司与九州通全擎健康产业（湖北）有限公司在武汉正式签署战略合作协议。此次合作标志着双方在医药健康领域的战略协同进入新阶段。长风药业长风药业以提高人类的生命质量和健康水平为己任，以开发高质量的呼吸系统用药为目标，致力于研发、生产和销售具有安全、有效、惠及大众的各类吸入制剂药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027100109a4767ed3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027100109a4767ed3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2577721841","title":"從本土突圍到全球破局，長風藥業港交所上市，劍指吸入製劑高地","url":"https://stock-news.laohu8.com/highlight/detail?id=2577721841","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577721841?lang=zh_tw&edition=fundamental","pubTime":"2025-10-20 20:22","pubTimestamp":1760962957,"startTime":"0","endTime":"0","summary":"长风药业成立于2013年，主要专注于呼吸系统疾病领域药物的研发、生产和销售。市场层面，2024年，呼吸系统疾病占全球医药市场约6.5%。以中国布地奈德吸入药物市场为例，2024年按销量计，长风药业CF017已占据约16%的市场份额，成为国产企业中的重要参与者。吸入制剂技术门槛高，长风药业不仅是少数几家拥有广泛吸入制剂产品组合的公司之一，也是国内少有的立足中国、面向全球的吸入制剂研发企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020215450a6c3e9b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020215450a6c3e9b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2576029690","title":"200億，中國藥谷又跑出一個IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2576029690","media":"周律微金融","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576029690?lang=zh_tw&edition=fundamental","pubTime":"2025-10-19 00:01","pubTimestamp":1760803270,"startTime":"0","endTime":"0","summary":"此次长风药业成功IPO，不仅是一家创新药企成长的里程碑，更令苏州生物医药“IPO军团”再添一员。两位美籍博士带队，靠卖哮喘药干出一个IPO闯关IPO这一路，长风医药走得一波三折。其核心产品CF017是中国销量最高的吸入药物类别。2021年5月获批后，迅速纳入国家集采，凭借“价格优势+疗效稳定”快速放量，长风药业的市场推广体系使CF017成功覆盖了中国超过一万家医疗机构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251019001200a6c07b8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251019001200a6c07b8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09939","BK1515","02652","06978"],"gpt_icon":0},{"id":"2576055537","title":"長風速遞丨長風藥業治療肺氣腫領域的微創介入器械完成首例入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2576055537","media":"中国医药创新促...","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576055537?lang=zh_tw&edition=fundamental","pubTime":"2025-10-17 17:39","pubTimestamp":1760693947,"startTime":"0","endTime":"0","summary":"本文转载自长风药业——面向肺气肿的微创介入治疗进入临床验证新阶段2025年10月17日，中国广州— 近日，长风药业股份有限公司自研支气管活瓣肺减容装置成功完成首例受试者入组，本临床验证阶段由此正式拉开帷幕，旨在为肺气肿等慢阻肺相关人群拓展一条微创介入治疗路径。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017184912a464ff00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017184912a464ff00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2576283704","title":"港股異動 | 長風藥業(02652)午前漲近3% 公司治療肺氣腫領域的微創介入器械完成首例入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2576283704","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576283704?lang=zh_tw&edition=fundamental","pubTime":"2025-10-17 11:49","pubTimestamp":1760672960,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，长风药业午前涨近3%，截至发稿，涨2.74%，报29.2港元，成交额536.45万港元。消息面上，据长风药业官微消息，近日，长风药业自研支气管活瓣肺减容装置成功完成首例受试者入组，本临床验证阶段由此正式拉开帷幕，旨在为肺气肿等慢阻肺相关人群拓展一条微创介入治疗路径。据介绍，肺气肿患者常见动态过度充气与活动受限，现有疗法在实现长效管理与显著改善生活质量方面，存在大量未满足的临床需求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652"],"gpt_icon":0},{"id":"2576005557","title":"是時候在一個新的維度看長風藥業的「藥械組合」了，一口呼吸如何撬動千億級藍海？","url":"https://stock-news.laohu8.com/highlight/detail?id=2576005557","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576005557?lang=zh_tw&edition=fundamental","pubTime":"2025-10-17 08:05","pubTimestamp":1760659502,"startTime":"0","endTime":"0","summary":"长风药业通过器械与药物双路径切入，有望在细分赛道形成协同效应。COPD作为一种常见的慢性呼吸道疾病，是全球第三大主要死亡原因，我国COPD患者超1亿人。重度肺气肿患者长期面临动态过度充气、运动受限与急性加重风险，现有药物对肺过度充气与肺弹性回缩改善有限。目前，全球尚无获批的IPF吸入药物。两者均体现了长风药业在微创介入与吸入递送方面的技术积累。据了解，目前长风药业已上市的旗舰药物包括CF017和CF018。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017082800a464145c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017082800a464145c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2575741713","title":"中國創新藥市場爆發，港股迎來呼吸製劑明星","url":"https://stock-news.laohu8.com/highlight/detail?id=2575741713","media":"子弹财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575741713?lang=zh_tw&edition=fundamental","pubTime":"2025-10-16 20:32","pubTimestamp":1760617923,"startTime":"0","endTime":"0","summary":"而此次成功IPO，则进一步揭开了这位呼吸制剂龙头的“神秘面纱”。面向未来，长风药业等创新药企仍要凭借市场、政策、行业的多重利好条件，实现进一步成长。市场需求的增长，无疑将为长风药业这位呼吸制剂行业“龙头”带来更好的发展契机。一系列政策的支持，不仅为中国创新药研发打了一针强心剂，也为药企带来了利好。4结语近年来，中国创新药在全球医药市场中的影响力不断攀升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016210832a6bd16b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016210832a6bd16b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652","06978","BK1574","BK1161"],"gpt_icon":0},{"id":"2575136797","title":"長風藥業10月16日主力淨流出43.7萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2575136797","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575136797?lang=zh_tw&edition=fundamental","pubTime":"2025-10-16 16:15","pubTimestamp":1760602551,"startTime":"0","endTime":"0","summary":"10月16日, 长风药业股价跌0.98%，报收28.42元，成交金额1026.0万元，换手率0.12%，振幅5.09%，量比0.23。长风药业今日主力资金净流出43.7万元，上一交易日主力净流入55.1万元。该股近5个交易日下跌14.19%，主力资金累计净流入5.2万元；近20日主力资金累计净流出220.1万元，其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016161948a6bcabe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016161948a6bcabe7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2575904167","title":"長風速遞丨長風藥業吸入創新藥入選蘇州市「關鍵核心技術攻關」項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2575904167","media":"长风药业","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575904167?lang=zh_tw&edition=fundamental","pubTime":"2025-10-16 15:18","pubTimestamp":1760599105,"startTime":"0","endTime":"0","summary":"——面向肺纤维化的首创机制吸入疗法，凭借直达病灶与可产业化路径获立项支持2025年10月15日，中国苏州——苏州市科技局公布2025年“关键核心技术攻关”项目立项清单。长风药业股份有限公司面向肺纤维化的全球首创吸入创新药项目成功获批。目前，全球尚无获批的IPF吸入药物。推荐阅读●长风速递丨长风药业吸入小核酸药物研发子公司入驻BioBAY！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016152024a462cd80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016152024a462cd80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06978","02652","BK1161"],"gpt_icon":0},{"id":"2575386417","title":"長風藥業(2652.HK)登陸港股，稀缺性、成長性與確定性兼具","url":"https://stock-news.laohu8.com/highlight/detail?id=2575386417","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575386417?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 21:25","pubTimestamp":1760534720,"startTime":"0","endTime":"0","summary":"聚焦到此次上市的长风药业，其作为拥有深厚技术沉淀、规模化生产能力、并取得优异商业化成果的国内领先吸入制剂企业，公司展现出了强大的竞争优势，有望长期受益于行业国产替代的新机遇。财务数据显示，2022-2024年长风药业的收入从3.49亿元人民币增长至6.08亿元，年复合增长率达31.9%。同时此番上市，长风药业也将是港股市场稀缺的纯正吸入制剂平台型企业，具备技术、产能、品牌等多重壁垒。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101521254694caf2ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101521254694caf2ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":1},{"id":"2575820192","title":"長風藥業10月15日獲主力加倉55.1萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575820192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575820192?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 16:15","pubTimestamp":1760516148,"startTime":"0","endTime":"0","summary":"10月15日, 长风药业股价涨3.76%，报收28.70元，成交金额1136.4万元，换手率0.13%，振幅6.44%，量比0.09。长风药业今日主力资金净流入55.1万元，上一交易日主力净流入12.4万元。该股近5个交易日下跌25.45%，主力资金累计净流出176.4万元；近20日主力资金累计净流出176.4万元，其中净流出天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015162028972f3c59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015162028972f3c59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"2575475171","title":"長風藥業10月13日主力淨流出26.8萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2575475171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575475171?lang=zh_tw&edition=fundamental","pubTime":"2025-10-13 16:15","pubTimestamp":1760343336,"startTime":"0","endTime":"0","summary":"10月13日, 长风药业股价跌5.95%，报收29.08元，成交金额5988.4万元，换手率0.68%，振幅5.82%，量比0.00。长风药业今日主力资金净流出26.8万元，上一交易日主力净流入8.2万元。该股近5个交易日上涨96.61%，主力资金累计净流出243.9万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出243.9万元，其中净流出天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101316184394c6169c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101316184394c6169c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0},{"id":"1171642663","title":"一週港股牛熊榜 | 周內飆升26%！恒生銀行獲滙豐私有化；中興通訊周升16%，股價本週創新高；山高控股周跌25%，遭恒生公司官宣剔除系列指數","url":"https://stock-news.laohu8.com/highlight/detail?id=1171642663","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171642663?lang=zh_tw&edition=fundamental","pubTime":"2025-10-10 16:59","pubTimestamp":1760086761,"startTime":"0","endTime":"0","summary":"本周市值百亿以上、日均成交千万以上表现最好五只股票是 $博泰车联(02889)$ 、$恒生银行(00011)$、 $智云科技建设-新(09900)$ 、 $经纬天地(02477)$、 $中兴通讯(00763)$ ；","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c0fa34192cf9918d1ecf43e4d024cc91","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02889","HSTECH","HSI","02477","09969","02228","09995","HSCEI","00412","02652","00011","00763","09900"],"gpt_icon":1},{"id":"2574128679","title":"越亞半導體擬募資超12億，18C企業魔視智能、森億智能遞表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2574128679","media":"Ofweek光电信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574128679?lang=zh_tw&edition=fundamental","pubTime":"2025-10-10 15:25","pubTimestamp":1760081100,"startTime":"0","endTime":"0","summary":"招股书显示，越亚半导体拟发行量不低于9907.48万股、不超过1.57亿股，计划募集资金12.24亿元，将用于面向AI领域的高效能嵌埋封装模组扩产项目、研发中心项目和补充流动资金。财务数据方面，2022年至2024年，越亚半导体分别实现营业收入16.67亿元、17.05亿元、17.96亿元，实现归母净利润分别为4.15亿元、1.88亿元、2.15亿元。珠海越亚曾于2014年向上交所递交上市申请，但后因业绩跳水、客户依赖等问题，IPO遭终止审查。递交上市申请9月","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010155325a4592ba7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010155325a4592ba7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["91292","02652","02583","02670","02259","02650"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":57,"code":"91000000","status":"200"}]}}